Zobrazeno 1 - 10 of 59 pro vyhledávání: '"Juan Manuel Palacios"'
1
Akademický článek
Necrotising hepatobacterium (NHPB) infection in penaeusvannamei with florfenicol and oxytetracycline: a comparative experimental study
Autor: María Soledad Morales Covarrubias, Lourdes Tlahuel Vargas, Irma Eugenia Martínez Rodríguez, Rodolfo Lozano Olvera, Juan Manuel Palacios Arriaga
Publikováno v: Revista Científica, Vol 22, Iss 1 (2012)
The present study is aimed to necrotising hepatobacterium (NHPB) infection, development in juvenile of Penaeus vannameiwith florfenicol (FF) (1.000g/kg biomass) and oxytetracycline (OTC) (6.070 g/kg biomass). HPLC analysis was used to confirm the ant
Externí odkaz: https://doaj.org/article/6971024f49354c3688d8d3f5c457450d
Zobrazit plný text záznamu
2
Acute Myocardial Infarction of the Left Main Coronary Artery Secondary to Embolism
Autor: Anival Trujillo Garcia, Enrique Verdugo Castro, Juan Manuel Palacios Rodriguez
Publikováno v: Clinical Cardiology and Cardiovascular Interventions. 5:01-04
There are few reported cases of left main artery embolism and is usually fatal, the importance of atrial fibrillation as a cause of acute myocardial infarction and the treatment these patients should be offered, this case highlights the challenges fa
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0bac3dd28b8da22f7113445722726031
https://doi.org/10.31579/2641-0419/282
Zobrazit plný text záznamu
6
Model‐based meta‐analysis of the time to first acute urinary retention or benign prostatic hyperplasia‐related surgery in patients with moderate or severe symptoms
Autor: Oscar Della Pasqua, Matthias Oelke, Chandrashekhar Chavan, Martin C. Michel, Michael J. Manyak, Claus G. Roehrborn, Juan Manuel Palacios-Moreno, Salvatore D'Agate
Publikováno v: British Journal of Clinical Pharmacology
Aims Combination therapy of 5α‐reductase inhibitor and α‐blocker is a guideline‐endorsed therapeutic approach for patients with moderate‐to‐severe lower urinary tract symptoms or benign prostatic hyperplasia (LUTS/BPH) who are at risk of
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ce0ad2b516afbceca8f6717ec01921f
https://doi.org/10.1111/bcp.14682
Zobrazit plný text záznamu
8
Understanding Treatment Response in Individual Profiles of Men with Prostatic Enlargement at Risk of Progression
Autor: Stavros Gravas, Juan Manuel Palacios-Moreno, Douglas Thompson, Federico Concas, Piotr J. Kamola, Claus G. Roehrborn, Matthias Oelke, Michael W. Kattan, Marcio Augusto Averbeck, Michael Manyak, Vanessa Cortés, Zrinka Lulic
Publikováno v: European urology focus.
It is unclear how cumulative multivariable effects of clinically relevant covariates impact response to pharmacological treatments for lower urinary tract symptoms (LUTS)/benign prostatic enlargement (BPE).To develop models to predict treatment respo
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95fbbda47a9ef6c80f68ab74aedbda27
https://pubmed.ncbi.nlm.nih.gov/35985933
Zobrazit plný text záznamu
9
Model‐based meta‐analysis of individual International Prostate Symptom Score trajectories in patients with benign prostatic hyperplasia with moderate or severe symptoms
Autor: Burkay Adalig, Oscar Della Pasqua, Timothy Wilson, Salvatore D'Agate, Claus G. Roehrborn, Juan Manuel Palacios-Moreno, Matthias Oelke, Michael J. Manyak, Chandrashekhar Chavan
Publikováno v: British Journal of Clinical Pharmacology
Aims International Prostate Symptom Score (IPSS) is a marker of lower urinary tract symptoms (LUTS) deterioration or improvement in benign prostate hyperplasia (BPH). Whereas changes in IPSS relative to baseline have been used as endpoints in clinica
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c1d7281a913483ead93d122f7c1c39d
http://europepmc.org/articles/PMC7373698
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje